Clinical Trial Update: Semaglutide for Post-Smoking Cessation Weight Management [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating semaglutide for weight management after smoking cessation, currently recruiting at UTHealth.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Obesity, Overweight | Phase 2 | Status: RECRUITING